Brief: Shanghai Heartcare Medical Technology Says FY Loss Attributable RMB200.4 Million
20/03/2023 12:28
March 20 (Reuters) - Shanghai HeartCare Medical
Technology 6609.HK :
* FY LOSS ATTRIBUTABLE RMB200.4 MILLION VERSUS LOSS OF
RMB194.2
MILLION
* FY REVENUE RMB183 MILLION, UP 103.2%
* FY REVENUE RMB183 MILLION VERSUS RMB90.1 MILLION
* CURRENTLY EXPECTED CLINICAL TRIALS IN MAINLAND CHINA NOT
BE
SIGNIFICANTLY AFFECTED BY OUTBREAK OF COVID-19
Further company coverage: 6609.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Shanghai HeartCare Medical Technology
See all newsBrief: Shanghai Heartcare Medical Technology Says Board Did Not Declare Payment Of An Interim Dividend
China's HeartCare Medical H1 revenue surges on stroke segment growth
Brief: Shanghai Heartcare Medical Technology Expects HY Revenue Of No Less Than Rmb280 Million
Brief: Shanghai Heartcare Medical Technology Approves H Share Repurchase Plan Up To HKD100 Million For Up To 1 Million H Shares
Brief: Shanghai HeartCare Medical Technology Sees FY PBT RMB80 Million